Royce & Associates’s Cross Country Healthcare CCRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
|
|||||
2024
Q4 | $21.3M | Buy |
|
|||||
2024
Q3 | $15.2M | Buy |
|
|||||
2024
Q2 | $10.4M | Sell |
|
|||||
2024
Q1 | $16.2M | Sell |
|
|||||
2023
Q4 | $23M | Buy |
|
|||||
2023
Q3 | $22.5M | Buy |
|
|||||
2023
Q2 | $22.2M | Buy |
|
|||||
2023
Q1 | $14.6M | Buy |
|
|||||
2022
Q4 | $15.2M | Sell |
|
|||||
2022
Q3 | $21.3M | Sell |
|
|||||
2022
Q2 | $24.7M | Buy |
|
|||||
2022
Q1 | $22.2M | Buy |
|
|||||
2021
Q4 | $23.5M | Sell |
|
|||||
2021
Q3 | $23.3M | Sell |
|
|||||
2021
Q2 | $25.2M | Sell |
|
|||||
2021
Q1 | $23.7M | Buy |
|
|||||
2020
Q4 | $15.7M | Buy |
|
|||||
2020
Q3 | $11.1M | Buy |
|
|||||
2020
Q2 | $10.2M | Buy |
|
|||||
2020
Q1 | $10.5M | Sell |
|
|||||
2019
Q4 | $18.9M | Sell |
|
|||||
2019
Q3 | $16.8M | Buy |
|
|||||
2019
Q2 | $14.6M | Buy |
|
|||||
2019
Q1 | $8.55M | Buy |
|
|||||
2018
Q4 | $8.21M | Sell |
|
|||||
2018
Q3 | $10.2M | Buy |
|
|||||
2018
Q2 | $11.9M | Buy |
|
|||||
2018
Q1 | $11.5M | Buy |
|
|||||
2017
Q4 | $12.3M | Buy |
|
|||||
2017
Q3 | $12.2M | Buy |
|
|||||
2017
Q2 | $10.2M | Buy |
|
|||||
2017
Q1 | $8.32M | Buy |
|
|||||
2016
Q4 | $4.57M | Buy |
|
|||||
2016
Q3 | $2.03M | Buy |
|
|||||
2016
Q2 | $2.3M | Sell |
|
|||||
2016
Q1 | $2.04M | Hold |
|
|||||
2015
Q4 | $2.88M | Sell |
|
|||||
2015
Q3 | $2.95M | Sell |
|
|||||
2015
Q2 | $3.05M | Hold |
|
|||||
2015
Q1 | $2.85M | Sell |
|
|||||
2014
Q4 | $3.13M | Sell |
|
|||||
2014
Q3 | $2.58M | Hold |
|
|||||
2014
Q2 | $1.81M | Hold |
|
|||||
2014
Q1 | $2.24M | Sell |
|
|||||
2013
Q4 | $3.97M | Sell |
|
|||||
2013
Q3 | $3.42M | Hold |
|
|||||
2013
Q2 | $2.91M | Buy |
|